September 10, 2025 · Form 4 insider transaction
LaBrosse Nicole bought 11,271 shares of Halozyme Therapeutics, Inc. at $12.07 per share, a transaction worth $136.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The option exercises and sales reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025.